steventong.bsky.social
Infectious diseases, clinical trials, staphylococcus and streptococcus. Reader and runner. Go Hawks!
👤 Joined on 11 October 2024
Followers
Following
Total Posts
@steventong.bsky.socialThe small print. Relapse occurred in 13 patients (5.1%) with tailored therapy and in 4 patients (1.6%) with standard therapy (P=0.04). Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis | New England Journal of Medicine www.nejm.org/doi/full/10....
Show PostLet’s go @idweek.bsky.social #IDWeek2026
Show PostHere's an update on my story in August about scientists using AI to make viruses. Now a startup has put AI viruses in a patient, to test them as a treatment called phage therapy. Gift link: nyti.ms/47pOLJv
Show PostFor all the fellows at IDWeek, I’ll be answering any questions you may have about clinical practice. Will also be at the MedTalk on Thursday morning also! This is all the stuff you don’t learn in your fellowship training but need to know as you walk into your new careers! Hope to see you there ☺️
Show PostDuring the 2019–25 period, the cumulative risk of HIV was 53·0% for females and 32·0% for males by age 54. Terrifying. www.sciencedirect.com/science/arti...
Show Post